Dalcetrapib
SIGMA/SML2091 - ≥97% (HPLC)
Synonym: JTT-705; RO-4607381; S-
CAS Number: 211513-37-0
Empirical Formula (Hill Notation): C23H35NO2S
Molecular Weight: 389.59
MDL Number: MFCD06407886
Linear Formula: C23H35NO2S
Product Type: Chemical
| assay | ≥97% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C23H35NO2S/c1-5-18(6-2 |
| InChI key | YZQLWPMZQVHJED-UHFFFAOYSA |
| SMILES string | CC(C)C(SC1=CC=CC=C1NC(C2( |
| solubility | DMSO: 2 mg/mL, clear |
| storage temp. | −20°C |
| Biochem/physiol Actions: | Cholesteryl ester transfer protein (CETP) inhibitor; increases serum levels of HDL-cholesterol |
| Biochem/physiol Actions: | Dalcetrapib is a cholesteryl ester transfer protein (CETP) inhibitor. It increases HDL levels, but showed variable results on clinical outcomes. Clinical outcomes, effects on C-reactive protein and cholesterol efflux have been found to be genotype-dependent, influenced by correlated polymorphisms in the ADCY9 (adenylate cyclase type 9) gene. Positive results were obtained with AA genotype of ADCY9 gene whereas the GG genotype showed negative results and the AG genotype was neutral. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥97% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |
